Gilead Sciences Stock Current Ratio

GILD Stock  USD 73.55  0.54  0.74%   
Gilead Sciences fundamentals help investors to digest information that contributes to Gilead Sciences' financial success or failures. It also enables traders to predict the movement of Gilead Stock. The fundamental analysis module provides a way to measure Gilead Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gilead Sciences stock.
As of March 28, 2024, Current Ratio is expected to decline to 1.39.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Gilead Current Ratio Analysis

Gilead Sciences' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Gilead Sciences Current Ratio

1.46

Current Ratio

 = 

Current Asset

Current Liabilities

More About Current Ratio | All Equity Analysis

Current Gilead Sciences Current Ratio

    
  1.43 X  
Most of Gilead Sciences' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gilead Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Gilead Current Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Gilead Sciences is extremely important. It helps to project a fair market value of Gilead Stock properly, considering its historical fundamentals such as Current Ratio. Since Gilead Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Gilead Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Gilead Sciences' interrelated accounts and indicators.
0.90.950.70.93-0.05-0.12-0.270.990.610.620.730.470.560.530.910.240.87-0.77-0.510.820.690.96-0.250.690.210.730.24-0.58-0.48-0.26
0.90.90.640.87-0.1-0.2-0.530.880.530.420.650.360.470.320.760.270.82-0.64-0.440.750.670.89-0.370.460.340.610.29-0.55-0.48-0.48
0.950.90.540.950.03-0.18-0.360.90.590.520.740.410.460.370.790.410.86-0.65-0.40.720.630.88-0.30.640.180.630.22-0.62-0.39-0.36
0.70.640.540.48-0.27-0.01-0.240.750.190.620.210.350.540.410.64-0.180.74-0.81-0.670.890.740.70.180.580.060.690.3-0.54-0.6-0.28
0.930.870.950.48-0.03-0.27-0.280.90.760.440.770.540.40.470.860.340.74-0.61-0.220.70.480.9-0.490.560.370.520.32-0.46-0.23-0.21
-0.05-0.10.03-0.27-0.030.210.47-0.090.23-0.310.27-0.11-0.260.060.040.44-0.30.40.27-0.46-0.450.02-0.21-0.360.28-0.130.210.430.270.36
-0.12-0.2-0.18-0.01-0.270.210.08-0.09-0.05-0.03-0.12-0.080.02-0.05-0.04-0.17-0.070.0-0.02-0.090.0-0.110.34-0.02-0.22-0.12-0.10.03-0.050.02
-0.27-0.53-0.36-0.24-0.280.470.08-0.230.05-0.11-0.040.08-0.030.35-0.050.04-0.530.20.24-0.44-0.53-0.210.05-0.20.0-0.1-0.070.550.320.9
0.990.880.90.750.9-0.09-0.09-0.230.60.640.710.490.580.580.930.160.85-0.8-0.540.830.70.96-0.230.690.220.750.24-0.55-0.49-0.21
0.610.530.590.190.760.23-0.050.050.60.150.580.750.020.440.750.190.21-0.310.320.34-0.10.69-0.710.110.680.020.460.10.320.21
0.620.420.520.620.44-0.31-0.03-0.110.640.150.170.520.40.210.5-0.050.66-0.9-0.60.630.670.520.270.7-0.450.64-0.42-0.58-0.38-0.19
0.730.650.740.210.770.27-0.12-0.040.710.580.170.120.330.470.790.520.52-0.28-0.280.320.320.76-0.330.330.350.580.22-0.11-0.380.09
0.470.360.410.350.54-0.11-0.080.080.490.750.520.120.060.320.55-0.020.18-0.610.230.440.00.51-0.420.210.280.010.09-0.030.370.17
0.560.470.460.540.4-0.260.02-0.030.580.020.40.330.060.650.470.010.58-0.57-0.670.540.640.490.220.64-0.170.73-0.08-0.46-0.63-0.1
0.530.320.370.410.470.06-0.050.350.580.440.210.470.320.650.650.110.25-0.36-0.250.370.160.58-0.250.460.250.470.290.0-0.180.36
0.910.760.790.640.860.04-0.04-0.050.930.750.50.790.550.470.650.170.65-0.68-0.350.70.470.96-0.290.530.390.640.35-0.24-0.340.08
0.240.270.41-0.180.340.44-0.170.040.160.19-0.050.52-0.020.010.110.170.120.030.0-0.13-0.020.24-0.31-0.02-0.010.21-0.020.05-0.010.03
0.870.820.860.740.74-0.3-0.07-0.530.850.210.660.520.180.580.250.650.12-0.77-0.730.870.930.760.10.81-0.130.790.07-0.86-0.72-0.57
-0.77-0.64-0.65-0.81-0.610.40.00.2-0.8-0.31-0.9-0.28-0.61-0.57-0.36-0.680.03-0.770.6-0.84-0.76-0.72-0.13-0.70.19-0.70.150.60.470.23
-0.51-0.44-0.4-0.67-0.220.27-0.020.24-0.540.32-0.6-0.280.23-0.67-0.25-0.350.0-0.730.6-0.56-0.89-0.42-0.54-0.640.45-0.90.230.620.930.36
0.820.750.720.890.7-0.46-0.09-0.440.830.340.630.320.440.540.370.7-0.130.87-0.84-0.560.80.770.010.750.070.640.31-0.71-0.53-0.41
0.690.670.630.740.48-0.450.0-0.530.7-0.10.670.320.00.640.160.47-0.020.93-0.76-0.890.80.580.350.76-0.340.83-0.13-0.85-0.86-0.6
0.960.890.880.70.90.02-0.11-0.210.960.690.520.760.510.490.580.960.240.76-0.72-0.420.770.58-0.340.570.360.690.34-0.37-0.41-0.12
-0.25-0.37-0.30.18-0.49-0.210.340.05-0.23-0.710.27-0.33-0.420.22-0.25-0.29-0.310.1-0.13-0.540.010.35-0.340.23-0.740.3-0.47-0.22-0.5-0.04
0.690.460.640.580.56-0.36-0.02-0.20.690.110.70.330.210.640.460.53-0.020.81-0.7-0.640.750.760.570.23-0.380.71-0.08-0.76-0.55-0.26
0.210.340.180.060.370.28-0.220.00.220.68-0.450.350.28-0.170.250.39-0.01-0.130.190.450.07-0.340.36-0.74-0.38-0.250.780.380.310.18
0.730.610.630.690.52-0.13-0.12-0.10.750.020.640.580.010.730.470.640.210.79-0.7-0.90.640.830.690.30.71-0.25-0.11-0.53-0.84-0.14
0.240.290.220.30.320.21-0.1-0.070.240.46-0.420.220.09-0.080.290.35-0.020.070.150.230.31-0.130.34-0.47-0.080.78-0.110.090.10.02
-0.58-0.55-0.62-0.54-0.460.430.030.55-0.550.1-0.58-0.11-0.03-0.460.0-0.240.05-0.860.60.62-0.71-0.85-0.37-0.22-0.760.38-0.530.090.590.74
-0.48-0.48-0.39-0.6-0.230.27-0.050.32-0.490.32-0.38-0.380.37-0.63-0.18-0.34-0.01-0.720.470.93-0.53-0.86-0.41-0.5-0.550.31-0.840.10.590.38
-0.26-0.48-0.36-0.28-0.210.360.020.9-0.210.21-0.190.090.17-0.10.360.080.03-0.570.230.36-0.41-0.6-0.12-0.04-0.260.18-0.140.020.740.38
Click cells to compare fundamentals

Gilead Current Ratio Historical Pattern

Today, most investors in Gilead Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Gilead Sciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Gilead Sciences current ratio as a starting point in their analysis.
   Gilead Sciences Current Ratio   
       Timeline  
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

Gilead Short Term Coverage Ratios

Short Term Coverage Ratios

4.23

At present, Gilead Sciences' Short Term Coverage Ratios is projected to decrease significantly based on the last few years of reporting.
In accordance with the recently published financial statements, Gilead Sciences has a Current Ratio of 1.43 times. This is 50.86% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current ratio for all United States stocks is 33.8% higher than that of the company.

Gilead Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gilead Sciences' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gilead Sciences could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics of similar companies.
Gilead Sciences is currently under evaluation in current ratio category among related companies.

Gilead Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Gilead Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Gilead Sciences' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Gilead Fundamentals

About Gilead Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Gilead Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gilead Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gilead Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Current Ratio 1.46  1.39 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Gilead Sciences Piotroski F Score and Gilead Sciences Altman Z Score analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.